Rafferty Asset Management
MYOK

Rafferty Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Rafferty Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,846
Closed -$388K – 1071
2020
Q3 		$388K Buy
2,846
+506
+22% +$53.8K ﹤0.01% 747
2020
Q2 		$226K Buy
+2,340
New +$195K ﹤0.01% 900
2020
Q1 		– Sell
-2,848
Closed -$208K – 880
2019
Q4 		$208K Sell
2,848
-1,090
-28% -$66.1K ﹤0.01% 842
2019
Q3 		$205K Buy
+3,938
New +$209K ﹤0.01% 779

Rafferty Asset Management's MYOK Position: Q4 2020 in Review

Rafferty Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 2,846 shares — an estimated $388K sold.

Rafferty Asset Management first reported a position in MYOK in Q3 2019 and held it in 4 quarters. The position peaked at $388K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Rafferty Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Rafferty Asset Management sold 2,846 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $388K.
  • Rafferty Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Rafferty Asset Management's MyoKardia, Inc. Common Stock position peaked at $388K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Rafferty Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.